Prostaglandin D2 causes preferential induction of proinflammatory Th2 cytokine production through an action on chemoattractant receptor-like molecule expressed on Th2 cells

Journal of Immunology

Volumn 175, Issue 10, 2005, Pages 6531-6536

  Xue, Luzheng ^a   Gyles, Shan L ^a   Wettey, Frank R ^a   Gazi, Lucien ^a,b   Townsend, Elizabeth ^a   Hunter, Michael G ^a   Pettipher, Roy ^a  

^a Oxagen Limited   (United Kingdom)

^b Bioparc   (France)

Author keywords

[No Author keywords available]

Indexed keywords

13,14 DIHYDRO 15 OXOPROSTAGLANDIN D2; 5 (6 CARBOXYHEXYL) 1 (3 CYCLOHEXYL 3 HYDROXYPROPYL)HYDANTOIN; 7 [3 [(4 PHENYLSEMICARBAZIDO)METHYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL] 5 HEPTENOIC ACID; ALLERGEN; BW 868C; CD28 ANTIGEN; CD3 ANTIGEN; CHEMOATTRACTANT; CHEMOATTRACTANT RECEPTOR LIKE MOLECULE EXPRESSED ON TH2 CELL RECEPTOR ANTAGONIST; CHEMOATTRACTANT RECEPTOR LIKE MOLECULE EXPRESSED ON TH2 CELLS; CHEMOATTRACTANT RECEPTOR LIKE MOLECULE EXPRESSED ON TH2 CELLS RECEPTOR; CYTOKINE; D PROSTANOID RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; PROSTAGLANDIN D2; PROSTAGLANDIN D2 SYNTHASE; PROSTAGLANDIN INHIBITOR; PROSTAGLANDIN RECEPTOR STIMULATING AGENT; PROSTAGLANDIN SYNTHASE; PROSTANOID RECEPTOR; RAMATROBAN; RECEPTOR; RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG; 13,14-DIHYDRO-15-KETOPROSTAGLANDIN D2; AUTACOID; CARBAZOLE DERIVATIVE; DNA; DRUG DERIVATIVE; HYDANTOIN DERIVATIVE; HYDRAZINE DERIVATIVE; IMMUNOGLOBULIN RECEPTOR; PROSTAGLANDIN D2 RECEPTOR; PROSTAGLANDIN RECEPTOR; SULFONAMIDE;

ALLERGIC INFLAMMATION; ALLERGIC REACTION; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; COSTIMULATION; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG EFFECT; EOSINOPHILIC LUNG INFLAMMATION; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; INFLAMMATION; LYMPHOCYTE ACTIVATION; MAST CELL; PNEUMONIA; PRIORITY JOURNAL; PROTEIN SECRETION; PROVOCATION TEST; TH2 CELL; TRANSGENIC MOUSE; BIOSYNTHESIS; CELL CULTURE; DRUG ANTAGONISM; DRUG POTENTIATION; GENETICS; IMMUNOLOGY; METABOLISM; NUCLEOTIDE SEQUENCE; UPREGULATION;

BASE SEQUENCE; CARBAZOLES; CELLS, CULTURED; CYTOKINES; DNA; HUMANS; HYDANTOINS; HYDRAZINES; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN-13; INTERLEUKIN-4; INTERLEUKIN-5; PROSTAGLANDIN D2; RECEPTORS, IMMUNOLOGIC; RECEPTORS, PROSTAGLANDIN; SULFONAMIDES; TH2 CELLS; UP-REGULATION;

EID: 27744514582     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.10.6531     Document Type: Article

References (39)

1. Robinson, D. S., Q. Hamid, S. Ying, A. Tsicopoulos, J. Barkans, A. M. Bentley, C. Corrigan, S. R. Durham, and A. B. Kay. 1992. Predominant Th2-like bronchoalveolar T lymphocyte population in atopic asthma. N. Engl. J. Med. 326: 298-304.
2. Bentley, A. M., Q. Meng, D. S. Robinson, Q. Hamid, A. B. Kay, and S. R. Durham. 1993. Increases in activated T lymphocytes, eosinophils, and cytokine mRNA expression for interleukin-5 and granulocyte/macrophage colony-stimulating factor in bronchial biopsies after allergen inhalation challenge in atopic asthmatics. Am. J. Respir. Cell Mol. Biol. 8: 35-42.
3. Robinson, D. S. 2000. Th2 cytokines in allergic diseases. Br. Med. Bull 56: 956-968.
4. Romagnani, S. 1992. Human Th1 and Th2 subsets: regulation of differentiation and role in protection and immunopathology. Int. Arch. Allergy Immunol. 98: 279-285.
5. Yamaguchi, Y., T. Suda, J. Suda, M. Eguchi, Y. Miura, N. Harada, A. Tominaga, and K. Takatsu. 1988. Purified IL-5 supports the terminal differentiation and proliferation of murine eosinophil precursors. J. Exp. Med. 167: 43-56.
6. Sehmi, R., A. J. Wardlaw, O. Cromwell, K. Kurihara, P. Waltmann, and A. B. Kay. 1992. Interleukin-5 selectively enhances the chemotactic response of eosinophils obtained from normal, but not eostnophilic subjects. Blood 79: 2952-2959.
7. Rothenberg M. E., J. Petersen, R. L. Stevens, D. S. Silberstein, D. T. McKenzie, K. F. Austen, and W. F. Owen, Jr. 1989. IL-5 dependent conversion of normodense human eosinophils to the hypodense phenotype uses 3T3 fibroblasts for enhanced viability, accelerated hypodensity and sustained antibody-dependent cytotoxicity. J. Immunol. 143: 2311-2316.
8. Wills-Karp, M., and M. Chiaramonte. 2003. Interleukin-13 in asthma. Curr. Opin. Pulm. Med. 9: 21-27.
9. Groux, H., and F. Cottrez. 2003. The complex role of interleukin-10 in autoimmunity. J. Autoimmun. 20: 281-285.
10. 2 generation after activation of rat and human mast cells with anti-IgE. J. Immunol. 129: 1627-1631.
11. Schleimer, R. P., C. C. Fox, R. M. Naclerio, M. Plaut, P. S. Creticos, A. G. Togias, J. A. Warner, A. Kagey-Sobotka, and L. M. Lichtenstein. 1985. Role of human basophils and mast cells in the pathogenesis of allergic diseases. J. Allergy Clin. Immunol. 76: 369-374.
12. 2 in BAL fluid after methacholine challenge in asthmatic subjects. Eur. Respir. J. 6: 405-412.
13. 2 receptors CRTH2 and DP. J. Allergy Clin. Immunol. 108: 982-988.
14. 2 receptor, CRTH2. J. Immunol. 168: 981-985.
15. 2 receptor CRTH2: structure, properties, and functions in leukocytes. Prostaglandins Leukot. Essent. Fatty Acids 69: 169-177.
16. 2-induced eosinophilic airway inflammation is mediated by CRTH2 receptor. J. Pharmacol. Exp. Ther. 312: 954-960.
17. 2, and selective DP1 and DP2 receptor agonists on pulmonary infiltration of eosinophils in Brown Norway rats. J. Pharmacol. Exp. Ther. 313: 64-69.
18. Fujitani, Y., Y. Kanaoka, K. Aritake, N. Uodome, K. Okazaki-Hatake, and Y. Urade. 2002. Pronounced eosinophilic lung inflammation and Th2 cytokine release in human lipocalin-type prostaglandin D synthase transgenic mice. J. Immunol. 168: 443-449.
19. 2 on helper T cell functions. Biochem. Biophys, Res. Commun. 316: 1009-1014.
20. McKenniff, M. G., P. Norman, N. J. Cuthbert, and P. J. Gardiner. 1991. BAY u3405, a potent and selective thromboxane A2 receptor antagonist on airway smooth muscle in vitro. Br. J. Pharmacol. 104: 585-590.
21. 2-induced eosinophil migration in vitro. J. Pharmacol. Exp. Ther. 305: 347-352.
22. 2 is a potent and selective CRTH2 receptor agonist and causes activation of human eosinophils and Th2 lymphocytes. Prostaglandins Other Lipid Mediat. 75: 153-167.
23. 2 into human airways during acute antigen challenge. N. Engl. J. Med. 315: 800-804.
24. 2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2. J. Exp. Med. 193: 255-261.
25. 2 is a potent chemoattractant for human eosinophils that acts via a novel DP receptor. Blood 98: 1942-1948.
26. Wills-Karp, M. 1999. Immunologic basis of antigen-induced airway hyperresponsiveness. Annu. Rev. Immunol. 17: 255-281.
27. Levy, F., C. Kristofic, C. Heuser, and V. Brinkman. 1997. Role of IL-13 in CD4 T cell dependent IgE production in atopy. Int. Arch. Allergy Immunol. 112: 49-58.
28. Romagnani, S. 1996. Th1 and Th2 in human diseases. Clin. Immunol. Immunopathol. 80: 225-235.
29. Ngoc, L. P., D. R. Gold, A. O. Tzianabos, S. T. Weiss, and J. C. Celedón. 2005. Cytokine, allergy, and asthma. Curr. Opin. Allergy Clin. Immunol. 5: 161-166.
30. Moore, K. W., R. de Waal Malefyt, R. L. Coffman, and A. O'Garra. 2001. Interleukin-10 and the interleukin-10 receptor. Ann. Rev. Immunol. 19: 683-693.
31. Fiorentino, D. F., A. Zlotnik, P. Vieira, T. R. Mosmann, M. Howard, K. W. Moore, and A. O'Garra. 1991. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J. Immunol. 146: 3444-3451.
32. de Waal Malefyt, R., J. Abrams, B. Bennett, C. G. Figdor, and J. E. de Vries. 1991. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174: 1209-1220.
33. Hashimoto, S., I. Komuro, M. Yamada, and K. S. Akagawa. 2001. IL-10 inhibits granulocyte-macrophage colony-stimulating factor-dependent human monocyte survival at the early stage of the culture and inhibits the generation of macrophages. J. Immunol. 167: 3619-3625.
34. Raisanen-Sokolowski, A., T. Glysing-Jensen, and M. E. Russell. 1998. Leukocyte-suppressing influences of interleukin (IL)-10 in cardiac allografts: insights from IL-10 knockout mice. Am. J. Pathol. 153: 1491-1500.
35. Madsen, K. L., D. Malfair, D. Gray, J. S. Doyle, L. D. Jewell, and R. N. Fedorak. 1999. Interleukin-10 gene-deficient mice develop a primary intestinal permeability defect in response to enteric microflora. Inflamm. Bowel Dis. 5: 262-270.
36. + T cell clones and peripheral blood T cells. J. Immunol. 149: 2378-2384.
37. Cousins, D. J., T. H. Lee, and D. Z. Staynov. 2002. Cytokine coexpression during human Th1/Th2 cell differentiation: direct evidence for coordinated expression of Th2 cytokines. J. Immunol. 169: 2498-2506.
38. Frazer, K. A., Y. Ueda, Y. Zhu, V. R. Gifford, M. R. Garofalo, N. Mohandas, C. H. Martin, M. J. Palazzolo, J. F. Cheng, and E. M. Rubin. 1997. Computational and biological analysis of 680 kb of DNA sequence from the human 5q31 cytokine gene cluster region. Genome Res. 7: 495-512.
39. Takemoto, N., Y. Kamogawa, H. J. Lee, H. Kurata, K. Arai, A. O'Garra, N. Arai, and S. Miyatake. 2000. Chromatin remodeling at the IL-4/IL-13 intergenic regulatory region for Th2-specific cytokine gene cluster. J. Immunol. 165: 6687-6691.